Vertex Pharmaceutic (VRTX)

Feb 18, 2025, 4:05 PM EST - 4 days ago

Vertex to Participate in Upcoming March Investor Conferences

Feb 18, 2025, 9:52 AM EST - 4 days ago

High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models

BLUE CVS

Feb 11, 2025, 2:21 PM EST - 11 days ago

Calls of the Day: Charles Schwab, Vertex Pharma and Transocean

RIG SCHW

Feb 11, 2025, 9:55 AM EST - 11 days ago

Vertex Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results

Feb 10, 2025, 8:26 PM EST - 11 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Q4 2024 Earnings Call Transcript

Feb 10, 2025, 4:40 PM EST - 12 days ago

Vertex Pharmaceuticals' Revenue Forecast Tops Expectations

Feb 10, 2025, 4:14 PM EST - 12 days ago

Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand

Feb 10, 2025, 4:01 PM EST - 12 days ago

Vertex Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 10, 2025, 10:20 AM EST - 12 days ago

Vertex Q4 Earnings On Deck: Will This Biotech Heavyweight Keep Its Edge?

Feb 10, 2025, 7:24 AM EST - 12 days ago

Top Wall Street Forecasters Revamp Vertex Pharmaceuticals Price Expectations Ahead Of Q4 Earnings

Feb 5, 2025, 1:30 PM EST - 17 days ago

Final Trades: Energy Transfer, Vertex Pharma, UnitedHealth and Axon Enterprise

AXON ET UNH

Feb 1, 2025, 10:17 PM EST - 20 days ago

Vertex: Maintaining Buy Despite Tempered Expectations For Journavx In Pain

Feb 1, 2025, 8:00 AM EST - 21 days ago

Vertex: YOY Decline In Q4 Earnings Expected, But Revenue Continues To Shine

Jan 31, 2025, 1:50 PM EST - 22 days ago

Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug

Jan 31, 2025, 11:39 AM EST - 22 days ago

FDA approves a new painkiller for the first time in decades

Jan 31, 2025, 10:36 AM EST - 22 days ago

Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval

Jan 31, 2025, 10:33 AM EST - 22 days ago

Vertex Pharmaceuticals CEO on non-opioid painkiller: It's safe, effective and non-addictive

Jan 31, 2025, 9:32 AM EST - 22 days ago

What's Happening With VRTX Stock?

Jan 31, 2025, 6:59 AM EST - 22 days ago

Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller

Jan 31, 2025, 6:52 AM EST - 22 days ago

FDA approves Vertex's non-opioid painkiller - first new kind of pain medicine in decades

Jan 31, 2025, 4:35 AM EST - 22 days ago

Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.

Jan 31, 2025, 2:00 AM EST - 22 days ago

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England

Jan 30, 2025, 7:55 PM EST - 22 days ago

FDA Approves Non-Opioid Painkiller With No Addiction Risk

Jan 30, 2025, 6:25 PM EST - 23 days ago

Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

Jan 30, 2025, 5:59 PM EST - 23 days ago

US FDA approves Vertex's non-opioid painkiller

Jan 30, 2025, 5:58 PM EST - 23 days ago

FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades

Jan 27, 2025, 7:30 AM EST - 26 days ago

Vertex to Announce Fourth Quarter and Full Year 2024 Financial Results on February 10

Jan 22, 2025, 11:05 AM EST - 4 weeks ago

Antibody Drug Conjugates Market Size is Expected to Reach USD 25.38 Billion by 2033, Growing at a CAGR of 8.84%: Straits Research

Jan 14, 2025, 2:47 PM EST - 5 weeks ago

Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials

Jan 13, 2025, 12:16 PM EST - 5 weeks ago

Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani Hosts 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Jan 12, 2025, 5:01 PM EST - 5 weeks ago

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Jan 10, 2025, 7:30 AM EST - 6 weeks ago

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

ZLAB

Jan 10, 2025, 7:30 AM EST - 6 weeks ago

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore

ZLAB

Jan 7, 2025, 12:23 PM EST - 6 weeks ago

Vertex Grapples With Bearish Chart As Death Cross Emerges

Jan 7, 2025, 7:00 AM EST - 6 weeks ago

Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)